பரிசோதனை வளர்ச்சி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from பரிசோதனை வளர்ச்சி. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In பரிசோதனை வளர்ச்சி Today - Breaking & Trending Today

Singapore enhances neutralizing antibody testing service


Singapore enhances neutralizing antibody testing service
Singapore enhances neutralizing antibody testing service
12 April 2021 | News
Image credit- prnewswire
GenScript Biotech Corporation, Parkway Laboratories and the Diagnostics Development (DxD) Hub announced their collaboration to provide the cPass™ SARS-CoV-2 neutralizing antibody test in Singapore through Parkway s panel of specialist and GP clinics.
Neutralizing antibodies are a small percentage of antibodies that bind to sites on the virus and inhibit entry of that virus into the host. Unlike the many COVID-19 lab-based antibody test kits commercially available, cPass™ can detect functional neutralizing antibodies.
Traditionally, measuring neutralizing antibodies requires the use of live virus, cells, highly skilled operators, and complex laboratory procedures that require several days in the laboratory to obtain results and limit their widespread use. ....

Health Sciences Authority , Diagnostics Development Dxd Hub , Drug Administration , Genscript Biotech Corporation , Parkway Laboratories , Diagnostics Development , Antibody Detection Kit , ஆரோக்கியம் அறிவியல் அதிகாரம் , பரிசோதனை வளர்ச்சி ட்கஷ்ட் மையம் , பரிசோதனை வளர்ச்சி , ஆன்டிபாடி கண்டறிதல் கிட் ,

New partnership to develop test for predicting disease course in pediatric Crohn's patients


New partnership to develop test for predicting disease course in pediatric Crohn s patients
The Crohn s & Colitis Foundation, the leading non-profit organization focused on both research and patient support for inflammatory bowel disease (IBD), has entered into a partnership with LifeArc, an independent medical research charity that advances translation of early science into health care treatments or diagnostics, to potentially develop the first clinical lab test to predict disease course in pediatric patients with Crohn s disease and response to treatment.
A prognostic test which could accurately predict which children will develop complications and identify patients most likely to benefit from anti-TNF therapy would help clinicians make effective early treatment decisions to improve outcomes. ....

Ciaran Fulton , Emily Henderson , Foundation Pediatric , Lifearc Centre For Diagnostics Development , Crohn Colitis Foundation , Translational Research , Colitis Foundation , Hurtado Lorenzo Phd , Vice President , Diagnostics Development , Associate Director , Crohn 39s Disease , Gene Expression , Health Care , Inflammatory Bowel Disease , Medical Research , எமிலி ஹென்டர்சன் , அடித்தளம் குழந்தை , குரோன் பெருங்குடல் அழற்சி அடித்தளம் , மொழிபெயர்ப்பு ஆராய்ச்சி , பெருங்குடல் அழற்சி அடித்தளம் , ஹர்டடோ லோரென்சோ ஃப்ட் , துணை ப்ரெஸிடெஂட் , பரிசோதனை வளர்ச்சி , இணை இயக்குனர் , கீந் வெளிப்பாடு ,